Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 12
Results: 15
Targeting CTCFL/BORIS for the immunotherapy of cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1955, doi. 10.1007/s00262-018-2251-8
- By:
- Publication type:
- Article
The role of CCR5 in directing the mobilization and biological function of CD11b<sup>+</sup>Gr1<sup>+</sup>Ly6C<sup>low</sup> polymorphonuclear myeloid cells in cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1949, doi. 10.1007/s00262-018-2245-6
- By:
- Publication type:
- Article
Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1845, doi. 10.1007/s00262-018-2244-7
- By:
- Publication type:
- Article
Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapies.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1833, doi. 10.1007/s00262-018-2241-x
- By:
- Publication type:
- Article
Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC).
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1825, doi. 10.1007/s00262-018-2239-4
- By:
- Publication type:
- Article
A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1853, doi. 10.1007/s00262-018-2236-7
- By:
- Publication type:
- Article
Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1815, doi. 10.1007/s00262-018-2235-8
- By:
- Publication type:
- Article
Dendritic cell trafficking in tumor-bearing mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1939, doi. 10.1007/s00262-018-2187-z
- By:
- Publication type:
- Article
Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1919, doi. 10.1007/s00262-018-2166-4
- By:
- Publication type:
- Article
Cystatin F as a regulator of immune cell cytotoxicity.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1931, doi. 10.1007/s00262-018-2165-5
- By:
- Publication type:
- Article
Personalized cancer vaccines: adjuvants are important, too.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1911, doi. 10.1007/s00262-018-2158-4
- By:
- Publication type:
- Article
Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1897, doi. 10.1007/s00262-018-2157-5
- By:
- Publication type:
- Article
Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe?
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1885, doi. 10.1007/s00262-018-2132-1
- By:
- Publication type:
- Article
Splice variants of human natural cytotoxicity receptors: novel innate immune checkpoints.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1871, doi. 10.1007/s00262-017-2104-x
- By:
- Publication type:
- Article
Cancer vaccine strategies: translation from mice to human clinical trials.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1863, doi. 10.1007/s00262-017-2084-x
- By:
- Publication type:
- Article